ROYAL BANK OF CANADA - NEURODERM LTD ownership

NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 74 filers reported holding NEURODERM LTD in Q2 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NEURODERM LTD
ValueSharesWeighting
Q3 2017$39,000
+85.7%
996
+42.3%
0.00%
Q2 2017$21,000
+10.5%
7000.0%0.00%
Q1 2017$19,000
+18.8%
7000.0%0.00%
Q4 2016$16,000
+23.1%
7000.0%0.00%
Q3 2016$13,000
+18.2%
7000.0%0.00%
Q2 2016$11,000
+10.0%
7000.0%0.00%
Q1 2016$10,000
-93.3%
700
-92.0%
0.00%
Q4 2015$149,000
+964.3%
8,736
+1148.0%
0.00%
Q3 2015$14,000
-33.3%
700
-48.8%
0.00%
Q2 2015$21,0001,3680.00%
Other shareholders
NEURODERM LTD shareholders Q2 2017
NameSharesValueWeighting ↓
OMNI PARTNERS LLP 1,116,596$43,436,0005.55%
Sandell Asset Management Corp. 1,128,950$43,916,0005.03%
First Trust Capital Management L.P. 422,771$16,446,0002.55%
Segantii Capital Management Ltd 152,676$5,939,0002.32%
Kassirer Asset Management Corp 59,989$2,334,0002.22%
S. MUOIO & CO. LLC 87,950$3,421,0001.76%
Kellner Capital, LLC 65,600$2,552,0001.72%
GABELLI & Co INVESTMENT ADVISERS, INC. 364,548$14,181,0001.64%
City Financial Investment Co Ltd 537,748$20,918,0001.32%
HAVENS ADVISORS LLC 45,750$1,780,0001.20%
View complete list of NEURODERM LTD shareholders